h virus trade with the new threat of the Hantavirus (andes strain) and the 8 week dormant period im looking at aug $60 calls if the inverse head n shoulders plays out all i need is dierction . if you look at mrna it is in a cup n handle fyi
Last report date
May 5, 2026
Report period
Q1 2026
EPS
0.75 USD
Revenue
14.45 B USD
1.31 USD
7.77 B USD
62.58 B USD
5.70 B
About Pfizer, Inc.
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
IPO date
Jan 17, 1944
Identifiers
3
ISIN US7170811035
Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Related stocks
Pfizer Value Setup: Dividend Support Could Push PFE HigherCurrent Price: 25.68 (Analysis was generated on Monday Morning)
Direction: LONG
Confidence level: 42%(Professional trader snippets are limited and do not provide strong directional signals, but X sentiment leans bullish and news analysis indicates Pfizer may be undervalued with strong dividend sup
Long
PFE | May, 2026 | The time to go long has come- Timeframe: Weekly
- Trade type: Buy stop order
- Price: 26.18
- Take Profit: Open
- Stop Loss: 25.24 (-3.50 %)
Idea: Long on a breakout above last week's high — bullish momentum continuation.
Entry: Buy stop above last week’s high.
Stop-loss: Below the low of the same candle.
If the weekly candle
Long
PFE — The Bigger Picture Points Toward $87 NYSE:PFE is not a daily-fluctuation story for me right now.
The bigger picture is more important.
On the monthly chart, PFE is sitting inside a long-term structural recovery area after years of decline from the 2021–2022 highs. Price is still weak in the short term, but the chart is no longer
Long
Pfizer (PFE) Setup: Traders Eye Pre‑Earnings Bounce Above $27Current Price: 26.33 (Analysis was generated on Monday Morning)
Direction: LONG
Confidence level: 58%(X sentiment shows bullish bias and recent pipeline news supports upside ahead of earnings, but YouTube trader coverage in the snippets is limited, reducing cross‑source confirmation.)
Targets
Tar
Long
PFE: Weekly Trendline Breakout + Strong Monthly Support ReboundOverview:
I am looking at a bullish reversal setup for Pfizer (PFE). The stock has been in a long-term consolidation phase and is now showing signs of a strong trend shift across multiple timeframes.
1. Monthly Timeframe (The Foundation):
As seen in the image, PFE has arrived at a major long-ter
Long
Pfizer Wave Analysis – 2 April 2026
- Pfizer broke resistance zone
- Likely to rise to resistance level 29.50
Pfizer recently broke the resistance zone between the resistance trendline of the daily Triangle from the start of February and the resistance level 27.6 (former multi-month high from October).
The breakout of this resista
Long
PFE - Pfizer: Investment Analysis Thoughts1️⃣ The world is in a state of permanent turbulence
After COVID, one thing became clear:
global systems can quickly shift into fear, uncertainty, and bio-risk mode.
Epidemics are no longer seen as something distant — the market is psychologically prepared for new waves.
➡️ For an investor, the key
Long
PFE target - $30.4NYSE:PFE looks good, ready for the 8% move, most likely this trade will work out.
Risk reward side it will be 1:1.2 trade, the downside is 6.38. it is wide. but if you go with probability, there is sure chance it will win. As the selling volume dries up and buy volume picks up.
Pfizer Breakout OpportunityNYSE:PFE Trade Overview: Pfizer (PFE) Long
I am executing a short-term swing trade based on a combination of technical patterns and momentum indicators, looking for a breakout above key resistance.
Technical Setup
Strategy: Short-term swing (2–15 day hold) using timeframe alignment.
Primary Signa
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of PFE is 25.33 USD — it hasn't changed in the past 24 hours. Watch Pfizer, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Pfizer, Inc. stocks are traded under the ticker PFE.
PFE stock has fallen by −1.78% compared to the previous week, the month change is a −7.32% fall, over the last year Pfizer, Inc. has showed a 11.83% increase.
We've gathered analysts' opinions on Pfizer, Inc. future price: according to them, PFE price has a max estimate of 36.00 USD and a min estimate of 24.00 USD. Watch PFE chart and read a more detailed Pfizer, Inc. stock forecast: see what analysts think of Pfizer, Inc. and suggest that you do with its stocks.
PFE stock is 0.79% volatile and has beta coefficient of 0.47. Track Pfizer, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pfizer, Inc. there?
Today Pfizer, Inc. has the market capitalization of 144.37 B, it has decreased by −1.86% over the last week.
Yes, you can track Pfizer, Inc. financials in yearly and quarterly reports right on TradingView.
Pfizer, Inc. is going to release the next earnings report on Aug 4, 2026. Keep track of upcoming events with our Earnings Calendar.
PFE earnings for the last quarter are 0.75 USD per share, whereas the estimation was 0.72 USD resulting in a 3.93% surprise. The estimated earnings for the next quarter are 0.68 USD per share. See more details about Pfizer, Inc. earnings.
Pfizer, Inc. revenue for the last quarter amounts to 14.45 B USD, despite the estimated figure of 13.84 B USD. In the next quarter, revenue is expected to reach 14.41 B USD.
PFE net income for the last quarter is 2.69 B USD, while the quarter before that showed −1.65 B USD of net income which accounts for 0.00% change. Track more Pfizer, Inc. financial stats to get the full picture.
Yes, PFE dividends are paid quarterly. The last dividend per share was 0.43 USD. As of today, Dividend Yield (TTM)% is 6.79%. Tracking Pfizer, Inc. dividends might help you take more informed decisions.
Pfizer, Inc. dividend yield was 6.91% in 2025, and payout ratio reached 126.85%. The year before the numbers were 6.37% and 120.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 19, 2026, the company has 75 K employees. See our rating of the largest employees — is Pfizer, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pfizer, Inc. EBITDA is 23.73 B USD, and current EBITDA margin is 37.87%. See more stats in Pfizer, Inc. financial statements.
Like other stocks, PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pfizer, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pfizer, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pfizer, Inc. stock shows the strong sell signal. See more of Pfizer, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.